Deep Nishar
About Deep Nishar
Dipchand (Deep) Nishar, age 56 as of March 31, 2025, has served as an independent director of Seer, Inc. since February 2021. He is a Managing Director at General Catalyst (since January 2022) and previously was Senior Managing Partner at SoftBank Investment Advisers (2015–2021). Earlier roles include product leadership at LinkedIn (SVP Product & UX) and Google (Senior Director of Products, APAC). He holds a B.Tech (IIT), M.S. in Electrical Engineering (University of Illinois Urbana-Champaign), and an MBA (Harvard Business School) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| SoftBank Investment Advisers (US) Inc. | Senior Managing Partner | Jun 2015–Dec 2021 | — |
| LinkedIn Corporation | VP Products; SVP Product & User Experience | Jan 2009–Oct 2014 | — |
| Google Inc. | Senior Director of Products, APAC (and other roles) | Aug 2003–Jan 2009 | — |
External Roles
| Organization | Role | Tenure | Committees/Notes |
|---|---|---|---|
| General Catalyst | Managing Director | Jan 2022–Present | Investment activities in life sciences |
| Dynamics Special Purpose Corp. | Director | May 2021–Jun 2022 | Public company board (SPAC) |
| Vir Biotechnology, Inc. | Director | Aug 2017–Jun 2022 | Public company board |
| Guardant Health, Inc. | Director | Oct 2018–Jun 2020 | Public company board |
| Relay Therapeutics, Inc. | Director | Jun 2019–Dec 2021 | Public company board |
| TripAdvisor, Inc. | Director | Aug 2013–Jun 2019 | Public company board |
| Zymergen Inc. | Director | Oct 2016–Sep 2020 | Public company board |
| Several privately-held companies | Director | Current | Not specified |
Board Governance
- Independence: The board determined Mr. Nishar is independent under Nasdaq standards; 5 of 7 directors are independent .
- Committee assignments (2025 proxy): Member, Corporate Governance & Nominating Committee (Chair: Nicolas Roelofs, Ph.D.); Member, Science & Technology Committee (Chair: Robert Langer, Sc.D.) .
- Attendance: In 2024, the board met 5 times; each director attended at least 75% of board and applicable committee meetings .
- Committee activity 2024: T&C Committee (5 meetings), Corporate Governance & Nominating (3 meetings), Science & Technology (1 meeting) .
- Board leadership: CEO serves as Chair; Lead Independent Director role held by Nicolas Roelofs since Aug 13, 2024 .
Fixed Compensation
-
2024 director fees paid to Deep Nishar: | Year | Fees Earned or Paid in Cash ($) | |---|---| | 2024 | 52,500 |
-
Outside Director Fee Schedule (policy amounts applicable in 2024/2025):
- Annual retainer: $42,500 (increased from $40,000 on Feb 28, 2024)
- Committee membership fees: CG&N member $5,000; Science & Technology member $5,000; Chair fees higher (CG&N Chair $10,000; S&T Chair $10,000)
- Lead Independent Director: $25,000
- Audit Committee member $10,000; Chair $20,000; T&C member $7,500; Chair $15,000
Note: Mr. Nishar’s $52,500 cash aligns with the policy math for 2024: $42,500 retainer + $5,000 (CG&N member) + $5,000 (S&T member) .
Performance Compensation
-
2024 equity to Deep Nishar: | Year | Stock Awards ($) | Option Awards ($) | |---|---|---| | 2024 | 108,793 | — |
-
Director Equity Program Details (policy mechanics and vesting): | Program Element | 2024 Policy | 2025 Policy (as amended Feb 26, 2025) | Vesting and Other Terms | |---|---|---|---| | Initial Award on joining board | Options for 69,470 shares + RSUs for 46,886 shares | Options for 61,000 shares + RSUs for 41,000 shares | Vests in 3 equal annual installments from start date, subject to service | | Annual Award at each AGM | RSUs for 58,178 shares | Options for 30,500 shares + RSUs for 20,500 shares | Vests in full on earlier of 1-year anniversary or day before next AGM; prorated if partial year of service | | Change in Control | — | Outstanding director equity vests fully if serving through change in control |
Other Directorships & Interlocks
- Current public company boards: None disclosed; currently serves on several privately-held company boards .
- Prior public company boards: Dynamics Special Purpose Corp. (2021–2022), Vir Biotechnology (2017–2022), Guardant Health (2018–2020), Relay Therapeutics (2019–2021), TripAdvisor (2013–2019), Zymergen (2016–2020) .
- Compensation committee interlocks: None reported for Seer’s T&C Committee in 2024; committee members were independent and no executive officer served on another company’s comp committee that had an executive serving on Seer’s board .
Expertise & Qualifications
- Technology and product leadership (Google, LinkedIn) and life sciences investing (SoftBank IA; General Catalyst) .
- Education: B.Tech (IIT), M.S. EE (UIUC), MBA (Harvard Business School) .
- Board-relevant skills cited by Seer: extensive technology background and investment activities in life sciences sector .
Equity Ownership
| Holder | Class A Shares Beneficially Owned | % of Class A Outstanding | Class B Shares | Notes |
|---|---|---|---|---|
| Dipchand (Deep) Nishar | 94,375 | <1% | — | As of Mar 31, 2025; ownership per SEC rules |
- Context: Total outstanding as of Mar 31, 2025 was 55,385,066 Class A and 4,044,969 Class B; Class B converts 1:1 into Class A and automatically converts on Dec 9, 2025 .
Governance Assessment
-
Strengths:
- Independent director with relevant tech and life science investing background; serves on governance and science/technology committees, aligning expertise with oversight needs .
- Attendance at least 75% of board/committee meetings in 2024, meeting typical governance thresholds .
- Director pay structure is equity-heavy (2024: $108,793 stock awards vs $52,500 cash), aligning interests with shareholders; policy updated in 2025 to include options plus RSUs, potentially increasing performance linkage for directors .
- No related-party transactions involving Mr. Nishar disclosed since January 1, 2023 .
-
Watch items:
- SoftBank SB Global Advisers Limited is a >5% stockholder; Mr. Nishar previously held a senior role at SoftBank Investment Advisers (ended 2021). The board has determined independence, and no related-party transactions are disclosed, but investors may monitor for potential perceived alignment issues given SoftBank’s stake .
- Seer does not disclose director stock ownership guidelines; the company notes no ownership guidelines for named executive officers (directors not specified), which some investors view as an alignment gap .
-
RED FLAGS: None disclosed specific to Mr. Nishar (no low attendance, no related-party transactions, no director-specific pay anomalies reported) .